Work

Changes in Mifepristone Use at Pharmacies After Removal of the FDA In-Person Dispensing Requirement

Year: 2026

Type: article

Abstract: This cross-sectional study examines access to mifepristone through retail and mail-order pharmacies following the US Food and Drug Administration’s (FDA) removal of its in-person dispensing requirement.

Source: JAMA

DOI: 10.1001/jama.2026.3419

Authors: Christopher Scannell, Pragya Kakani, Rebecca Myerson, Dima Mazen Qato

Institutions: University of Southern California, Cornell University, Weill Cornell Medicine, Emory University

Language: English

Topic: Reproductive Health and Contraception

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7154115866

FWCI: 6.215

Cites: 3

Cited by: 1

Related to: